Participate in an Alzheimer’s Research Study
If you or someone you love is experiencing memory loss, or has been diagnosed with Alzheimer’s disease, perhaps you should consider participating in a clinical research study. Participants receive a high standard of care, and research shows that people involved in clinical trials tend to do somewhat better than people in a similar stage of their disease who are not enrolled in clinical trials.*
Perhaps the best reason to participate in an Alzheimer’s clinical trial is so that you can take an active role in your health care, by educating yourself regarding your condition. You will obtain access to top quality medical care from our Board Certified physicians at a medical research healthcare facility specializing in Alzheimer’s care.
Health insurance is not necessary to participate. Patients who qualify for our clinical trials will receive all study related care and treatment at no cost. In some cases you may be compensated for your time and travel. You may even gain access to research treatments before they are widely available.
Without volunteers for clinical trials, improved treatments, including a cure for Alzheimer’s disease can never become a reality.
Premiere Research Institute is currently seeking volunteers for the A4 Study.
If you are a healthy older adult with normal memory, this could be the right time for you to join the fight to prevent the memory loss associated with Alzheimer’s disease.
What is the A4 study?
The Anti-Amyloid Treatment in Asymptomatic Alzheimer’s study (the “A4 study “for short) is a clinical study for older individuals (65 to 85 years of age) who may be at risk for the memory loss associated with Alzheimer’s disease (AD).
The A4 study is investigating a new drug intervention that may reduce the impact of a protein known as “amyloid” or “beta amyloid” forming plaques in the brain. Scientists believe that accumulation of amyloid in the brain may play a key role in the eventual development of AD-related memory loss. The A4 anti-amyloid investigational drug targets amyloid build-up in the brain with the aim of slowing memory loss associated with the development of AD.
Am I eligible?
The A4 study will enroll 1,000 people between the ages of 65 through 85 with normal thinking and memory function but with evidence of amyloid plaque buildup in the brain. Physicians and researchers will use PET amyloid imaging scans to determine whether a potential participant has evidence of elevated amyloid buildup. Individuals with elevated amyloid on the PET scan will be eligible to become participants in the A4 clinical study. People who do not show evidence of elevated brain amyloid may be asked to participate in a separate study. This group will not receive the study drug but will complete the same memory tests every six months to compare changes in cognition over time.
* Source: alz.org (official website for the Alzheimer’s Association)
Interested in learning more about A4? Contact Premiere Institute of Palm Beach by calling (561) 296-3850 or fill out the form below.
Articles about Alzheimer’s Disease
To read one of our most recent articles about Alzheimer’s Disease just click the title of the article.
The risk factors for Alzheimer's disease are non-modifiable, physiological, and behavioral. Non-modifiable risk factors include age, which is the most prominent risk factor for Alzheimer’s disease. At 65 years of age, our chances of getting Alzheimer’s disease is...read more
According to new research, inflammation brain changes related to Alzheimer’s disease may begin as early as 20 years before symptoms develop. This discovery has significant implications for prevention of the disease, since addressing the inflammation earlier in life...read more
Overview: Alzheimer’s disease is a chronic, degenerative and progressive disease of the brain characterized by a loss of neurons and synapses and is currently ranked as the 7th leading cause of death in the United States. According to the Alzheimer’s Association, an...read more
Over the years, there have been a growing number of studies that have revealed a link between hearing loss and dementia, which may in turn lead to Alzheimer’s if left untreated. In fact, research has shown that mild hearing loss may double the risk of dementia, while...read more
High blood pressure, or hypertension, is a growing health problem in many parts of the world that serves as a major risk factor for cardiovascular disease and stroke. In addition, new evidence is emerging on a significant association between high blood pressure and...read more
DIAGNOSTIC WORKUP: A few blood tests are necessary after physical and neurological exams have been conducted. To make a proper diagnosis, a complete blood chemistry is required to check liver and kidney function, as well as a blood count to see if the patient is...read more
Exercise Eat Healthy – AZ Prevention Diet/Stop Forgetting! Brain Training/Socialization A team of researchers from the Karolinska Institutet in Sweden and the National Institute for Health and Welfare in Finland found that older people who exercise, eat healthy and...read more
Peanut butter may serve a greater purpose than simply being fun to eat – the inability to smell it could help detect early-stage Alzheimer’s. Researchers at the University of Florida conducted a peanut butter smell test on study participants to determine if there is a...read more